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Abstract
Until now commercial animal cloning has been generally limited to 
breeding stock. But Xu Xiaochun of the Chinese company Boyalife 
Genetics plans to mass produce animal clones for direct meat 
consumption. The research partnership between Boyalife and South 
Korean firm Sooam Biotech suggests the possibility of an international 
market for cloned food animals.
Can cloned food imports be rejected by national governments? This 
Article outlines the relevant considerations, and argues that a revised 
understanding of the “precautionary principle” can help to reconcile 
disparate, and perhaps ineffable, goals like producing high-quality meat 
and maintaining the integrity of the human experience.
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INTRODUCTION
Animal and transgenic cloning is making headlines. In January 2017,
a team of scientists led by the Salk Institute announced that they had 
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created a chimera human–pig embryo.1 Supporters view this as a 
formative step to the production of lab-created organs for human patients. 
Pigs have notably similar organs to humans, and so scientists think these 
transgenic organs have correlatively less chance of “rejection risk.”2 But 
perhaps you share my reaction that human–pig hybrids are also a bit 
dystopic and icky. The brave new world of contemporary science offers 
innovative ways to alleviate human suffering and extend human life, but 
it also prompts debate about the integrity of the human experience and 
limits on human experimentation. The line-drawing problem between 
genetic therapy and enhancement is a difficult one, but there should be at 
least some set of universal standards or guidelines for tinkering with our 
human condition. The slippery-slope argument may suggest the 
connections between animal and human cloning. Another relevant trope 
is the domino effect: If one rogue nation begins creating its genetic uber-
human, other nations will be incentivized to join this eugenics race to the
bottom.3
The bioethical question has shifted from what is possible to what is 
acceptable.4 Princeton biologist Lee M. Silver posits that human cloning 
is inevitable: “If nuclear transplantation works in every mammalian 
species in which it has been seriously tried, then nuclear transplantation 
will work with human cells as well.”5 Still, even if resistance to a brave 
new world of human cloning reflects an effete sensibility or prudishness 
with the unknown, one could at minimum argue this is a project that 
requires international deliberation. The Declaration of Helsinki governs 
human research ethics;6 however, there is not any specific convention on 
human cloning or posthuman experimentation. There are proposals for 
international agreements, such as the Convention on the Preservation of 
the Human Species.7 But present legal restrictions on cloning are limited 
                                                                                                                     
1. Erin Blakemore, Human–Pig Hybrid Created in the Lab—Here Are the Facts, NAT’L
GEOGRAPHIC (Jan. 26, 2017), http://news.nationalgeographic.com/2017/01/human–pig-hybrid-
embryo-chimera-organs-health-science/.
2. Id.
3. Cf. George J. Annas et al., Protecting the Endangered Human: Toward an International 
Treaty Prohibiting Cloning and Inheritable Alterations, 28 AM. J.L. & MED. 151, 161–62 (2002)
(restating the argument that cloning will inevitably lead to attempts to create not just genetic 
duplicates, but better and better humans).
4. Jesper Lassen et al., After Dolly—Ethical Limits to the Use of Biotechnology on Farm 
Animals, 65 THERIOGENOLOGY 992, 993 (2006).
5. Lee M. Silver, Cloning, Ethics, and Religion, 7 CAMBRIDGE Q. HEALTHCARE ETHICS 
168, 169 (1998).
6. Jharna Mandal et al., Ethics in Human Research, TROPICAL PARASITOLOGY (2011), 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593469/.
7. Annas et al., supra note 3.
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to national or supranational documents8 and to individual state legislation 
within the United States.9 Part of this lack of consensus goes to 
definitional problems inherent in separating, for example, gene treatment 
to cure a “defect” from possible procedures to expand human capacity.10
Perhaps there is also a sense that cloning is a distant reality that only 
exists in science-fiction films. The “birth” of Dolly the Sheep inspired a 
burst of debate.11 But since that event there has been relatively little 
public debate—or at least very few legislative moves.
Big agriculture and other defenders of the free trade of cloned-animal 
products have suggested a bright-line separation of animal and human 
experimentation.12 The 1997 National Bioethics Advisory Committee 
had a similarly conclusory take on this (supposed) binary of animal vis-
à-vis human cloning: “[R]esearch on cloning animals . . . does not raise 
the issues implicated in attempting to use this technique for human 
cloning, and its continuation should only be subject to existing 
regulations regarding the humane use of animals and review by 
institution-based animal protection committees.”13 But topical stories on 
animal cloning bring into focus its implications for human 
experimentation.
A human–pig embryo can be rationalized. Lab-created organs have a 
decidedly utilitarian purpose and are visibly distinguishable from a 
proper full-size human clone. Most people do not self-identify by their
internal, discrete organs—indeed many already volunteer them to others. 
In vitro, or “cultured,” meat is analogous. In August 2013, the first lab-
grown burger “taste test” was celebrated in London.14 Google cofounder 
                                                                                                                     
8. E.g., Charter of Fundamental Rights of the European Union, art. 3(2), 2000 O.J. (C 364)
1, 9.
9. Laws and Public Policy About Cloning, CLONING—A WEBLIOGRAPHY,
http://staff.lib.msu.edu/skendall/cloning/laws.htm (last visited Oct. 8, 2017).
10. Faith Lagay, Gene Therapy or Genetic Enhancement: Does it Make a Difference?, 3 
AM. MED. ASS’N J. ETHICS (Feb. 2001), http://journalofethics.ama-assn.org/2001/02/gnth1-
0102.html.
11. Russell Blackford, Dolly the Sheep and the Human Cloning Debate – Twenty Years 
Later, CONVERSATION (Aug. 9, 2016), http://theconversation.com/dolly-the-sheep-and-the-
human-cloning-debate-twenty-years-later-63712.
12. John F. Murphy, Mandatory Labeling of Food Made from Cloned Animals: Grappling 
with Moral Objections to the Production of Safe Products, 63 FOOD & DRUG L.J. 131, 139 (2008) 
(“Despite the common association [between human and animal cloning] in the public mind, 
researchers in the animal cloning field scoff at the possibility.”).
13. Stacy J. Ratner, Note, Baa, Baa, Cloned Sheep, Have You Any Law? Legislative 
Responses to Animal Cloning in the European Union and United States, 22 B.C. INT’L & COMP.
L. REV. 141, 151 (1999) (quoting NAT’L BIOETHICS ADVISORY COMM’N, CLONING HUMAN 
BEINGS: REPORT AND RECOMMENDATIONS iv (1997)).
14. Trae Norton, From the Lab to the Supermarket: In Vitro Meat as a Viable Alternative 
to Traditional Meat Production, 11 J. FOOD L. & POL’Y 157, 165 (2015).
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Sergey Brin is a vanguard investor in this project to create economically 
viable in vitro meat alternatives,15 and since 2013 there has been 
significant progress in reducing costs.16 The promise of in vitro meat is 
the taste and nutrition of meat without the suffering. This should trump 
any intuition that in vitro meat is alien or unseemly.17 And besides, in 
vitro burgers look just like the natural kind, even if they are desiccated or 
bland.18 They don’t disturb the senses or internalized order of nature.
The assembly-line carcasses of the Boyalife factory are different. 
Until now animal cloning has been most associated with the boutique 
practice of re-producing cherished pets19 or the scientific quest to recreate
extinct species.20 The commercial viability of cloning food animals has 
been deemed remote.21 But Xu Xiaochun of the Chinese company 
Boyalife Genomics plans to bring mass production to animal cloning for 
direct meat consumption. The company expects to open a factory the size 
                                                                                                                     
15. Id. at 166.
16. See, e.g., Marta Zaraska, Lab-Grown Meat Is in Your Future, and It May Be Healthier 
Than the Real Stuff, WASH. POST (May 2, 2016), https://www.washingtonpost.com/national/
health-science/lab-grown-meat-is-in-your-future-and-it-may-be-healthier-than-the-real-stuff/
2016/05/02/aa893f34-e630-11e5-a6f3-21ccdbc5f74e_story.html?utm_term=.0b1f73aee2f3
(noting how a Dutch company spent $330,000 in 2013 to create a single hamburger, but an 
American company produced a pound of meatballs for $18,000 in 2016).
17. More specifically, challenging the notion that fake meat will prove a panacea for the 
eco-catastrophes wrought by modern meat industries, these artistic and literary forerunners of 
emergent scientific realities come to position meat substitutes in ways that trouble the linkage of 
the human subject with all forms of authority, and in so doing pursue deeper inquiry into whether 
and how fake meat leverages more responsive and responsible environmental ethics. E.g., Susan 
McHugh, Real Artificial: Tissue-Cultured Meat, Genetically Modified Farm Animals, and 
Fictions, 18 CONFIGURATIONS 181, 183 (2010).
18. Norton, supra note 14, at 165–66.
19. E.g., AFP–JIJI, Cost of Replicating Fido? $100,000 a Pup, Korean Cloning Clinic 
Says, JAPAN TIMES (July 4, 2016), https://web.archive.org/web/20160714193808/
http://www.japantimes.co.jp/news/2016/07/04/asia-pacific/science-health-asia-pacific/cost-of-
replicating-fido-100000-a-pup-korean-cloning-clinic-says/#.WZh-WWVMmIU (“With a client 
list including princes, celebrities and billionaires, the foundation offers owners protection against 
loss and grief with a cloning service that promises the perfect replacement for a beloved pet.”).
20. See Alejandro E. Camacho, Going the Way of the Dodo: De-Extinction, Dualisms, and 
Reframing Conservation, 92 WASH. U. L. REV. 849, 857 (2015) (“Advances in knowledge 
achieved through cloning efforts for extinct species could be used to engage in cloning for extant 
endangered species, particularly for species that have declined to only a few or single non-
reproducing individuals.”).
21. See, e.g., Murphy, supra note 12, at 134 (explaining why cloning food animals is cost 
prohibitive compared to breeding food animals); see also Chris Downes, The Rise and Fall of the 
New EU Novel Food Regulation: The Complex Influence of the WTO SPS Agreement, 8 ASIAN J.
WTO & INT’L HEALTH L. & POL’Y 249, 270 (2013) (“With a production cost for a single animal 
of around US$20,000, economics alone rules out such animals entering the food chain.”).
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of three American football fields soon in Tianjin,22 a mega-facility that 
will include a gene storage area and museum.23 The Boyalife Twitter feed 
has unveiled recent pictures of sleek, modern construction.24 The 
company also has more rarefied goals. According to Xiaochun, “cloned 
beef is the tastiest beef [he’s] had.”25 Boyalife aims to create a flavorful 
product to help fill a lack of high-quality beef in Mainland China.26
The company’s goal is ambitious: to produce 100,000 “top-quality” 
cow embryos per year, and eventually 5% of the premium cattle 
slaughtered in China.27 The research partnership between Boyalife and 
South Korean firm Sooam Biotech suggests the possibility of an 
international market for cloned food animals.28 This sci-fi play on the 
notion of farm-to-table is alarming.
This Article considers the implications of animal meat clones on 
patent and trade law. Clones fit awkwardly into current legal categories, 
notably whether an animal clone or its cloned meat is “novel.” This 
Article questions the continued utility of this construct of newness for 
thinking about already-living beings, specifically about whether these 
animal meat clones are meaningfully different from other sorts of cloned 
products in the global food supply chain. Can cloned-food imports be 
rejected by national governments? This Article outlines the available 
arguments and argues that a revised understanding of the “precautionary 
principle” can help to reconcile disparate, and perhaps ineffable, goals 
like producing high-quality meat and maintaining the integrity of the 
human experience.29
                                                                                                                     
22. John Hayward, Chinese Scientist Plans to Clone a Million Cows Per Year, BREITBART
(Jan. 4, 2016), http://www.breitbart.com/tech/2016/01/04/chinese-scientist-plans-clone-million-
cows-per-year/.
23. Michael Addady, China Will Start Cloning Cattle to Meet Rising Beef Demands,
FORTUNE (Dec. 1, 2015), http://fortune.com/2015/12/01/china-cloning-cattle/.
24. See generally Boyalife Group (@BoyalifeGroup), TWITTER,
https://twitter.com/BoyalifeGroup (last visited Oct. 8, 2017) (displaying pictures of Boyalife 
Group’s construction).
25. Tom Phillips, Largest Animal Cloning Factory Can Save Species, Says Chinese
Founder, GUARDIAN (Nov. 24, 2015, 12:27 AM), https://www.theguardian.com/world/2015/nov/
24/worlds-largest-animal-cloning-factory-can-save-species-says-chinese-founder.
26. Stephen M. Lepore, Chinese Cloning Firm ‘Won’t Make Frankensteins’ With Humans,
N.Y. DAILY NEWS (Dec. 28, 2015, 5:52 PM), http://www.nydailynews.com/news/world/cloning-
firm-no-plans-clone-humans-article-1.2479074.
27. Phillips, supra note 25.
28. Id.
29. See, e.g., Sophie M. Clavier, Food Fight at the WTO: Can the Precautionary Principle 
Reconcile Liberalization and Public Fear?, 16 CURRENTS: INT’L TRADE L.J. 3, 3 (2008).
5
Kerr: The Global Trade of Cloned Meat
Published by UF Law Scholarship Repository,
174 FLORIDA LAW REVIEW [Vol. 70
I. PUBLIC RESPONSES TO CLONING
This analysis is informed by a threshold claim that human and animal 
cloning are paired. The ethics question was hotly debated after the “birth” 
of Dolly, who of course “was in a radical sense fatherless.”30 The main 
critiques of the cloning project have clustered around animal-centric 
problems related to the quality of life of the individual animal, as well as 
more deontological concerns about “playing god”31 or animal 
autonomy.32 Xu Xiaochun has soothed human-use fears by reassuring 
that Boyalife will not embark on human cloning: “[W]e won’t make 
Frankensteins.”33 However, he has also opaquely referenced evolving 
“social values” and the possibility that his technologies could later benefit 
the human race.34 Even more disquieting is that Boyalife’s partner firm 
Sooam was founded by pariah Hwang Woo Suk.35 In 2004, Suk claimed 
to have created human embryos at the blastocyst stage,36 but his research 
was later derided as fraudulent.37 Critics rightly question his current 
intent in cloning pet dogs. If part of the legal justification for animal 
cloning is that it is cloistered from experimentation on humans, but the 
animal-cloning vanguard has been exposed as having broader human-
centric ambitions, then the constructed bright line between human–
mammal and nonhuman–mammal testing begins to erode. The legality of 
animal cloning seems to depend on the illegality of human cloning.
As a conditional question, one might ask: What is really wrong with 
animal cloning? After all, cloned animal products have been designated 
safe by the Food and Drug Administration (FDA),38 and people obviously 
already consume plant clones and genetically modified (GM) foods in 
large numbers. Cloning defenders argue that our visceral distaste for 
                                                                                                                     
30. Lassen et al., supra note 4, at 993.
31. Chris Slack, Association for Molecular Pathology v. Myriad Genetics, Inc.: What Are 
the Effects on Cloning Extinct Animals and Agriculture Now That cDNA Is Patentable?, 19 
DRAKE J. AGRIC. L. 347, 358 (2014).
32. Perhaps the “deep-ecological” argument could turn either way if endangered or recently 
extinct keystone species were reintroduced. Cf. Chad West, Economics and Ethics in the Genetic 
Engineering of Animals, 19 HARV. J.L. & TECH. 413, 429–30 (2006).
33. Hayward, supra note 22.
34. Id.
35. Rob Stein, Disgraced Scientist Clones Dogs, and Critics Question His Intent, NPR 
(Sept. 30, 2015, 3:01 PM), http://www.npr.org/sections/health-shots/2015/09/30/418642018/
disgraced-scientist-clones-dogs-and-critics-question-his-intent.
36. See Autumn Fiester, Ethical Issues in Animal Cloning, 48 PERSP. BIOLOGY & MED. 328, 
336 (2005).
37. Jung Ha-Won, Fido Forever? South Korea’s Dog Cloning Clinic, PHYS.ORG (July 4, 
2016), http://phys.org/news/2016-07-fido-korea-dog-cloning-clinic.html.
38. Maria Weimer, The Regulatory Challenge of Animal Cloning for Food—The Risks of 
Risk Regulation in the European Union, 1 EUR. J. RISK REG. 31, 33 (2010).
6
Florida Law Review, Vol. 70, Iss. 1 [], Art. 3
https://scholarship.law.ufl.edu/flr/vol70/iss1/3
2018] THE GLOBAL TRADE OF CLONED MEAT 175
cloned foods reflects a gestalt feeling rather than reasoned analysis. The 
U.S. Humane Society requested a ban on products coming from cloned 
animals as early as 2002.39 Defenders situate this skepticism of cloning 
within a broader lack of understanding about biotechnology. For 
example, in the weeks after Dolly’s arrival on the scene, 56% of surveyed 
Americans said they would not eat the meat of cloned animals.40
However, cloning defenders still lack data that goes to support their 
“knowledge deficit” theory. Eurobarometer surveys evidenced continued 
unease with animal cloning a decade after Dolly.41 A 2008 
Eurobarometer survey found that 61% of Europeans felt animal cloning 
to be morally wrong, and 77% believed it might lead to human cloning.42
Interestingly, The Roslin Institute that cloned Dolly in 1996 no longer 
works on animal cloning.43
One might parry: Do we really need animal cloning? Agricultural
science has already developed natural methods to mirror the benefits of 
genetic selection (for example, the Red Angus). Also, some of the 
proposed alternative benefits of animal cloning seem counterproductive. 
Boyalife also aims to clone sniffer dogs and champion racehorses.44 But 
does this take away from the magic and very premise of sport?45 So far 
the Sooam sniffer dog has been a lousy investment for the Russian police. 
The New York Post recently reported how these dogs, at a price tag of 
$100,000 each, have mostly flunked administered skills tests.46
Defenders of animal cloning also refer to comparative levels of pain 
and suffering for naturally reproducing animals on factory farms.47 The 
argument goes: Sure, most cloned animals die young or suffer awful 
lives, but the same is true of animals on industrial farms.48 Today there is 
more contestation over the moral legitimacy of industrial farming.49 This 
supposed control or foil to animal cloning is no longer considered a valid 
counterpoint.
                                                                                                                     
39. Fiester, supra note 36, at 332.
40. Silver, supra note 5, at 168.
41. Lassen et al., supra note 4, at 994.
42. Weimer, supra note 38, at 35.
43. Gretchen Vogel, E.U. Parliament Votes to Ban Cloning of Farm Animals, SCIENCE
(Sept. 8, 2015, 1:15 PM), http://www.sciencemag.org/news/2015/09/eu-parliament-votes-ban-
cloning-farm-animals.
44. Phillips, supra note 25.
45. See generally Laura E. Peet, One-Trick Genes? A Look at the Legality of Banning 
Animal Clones from Commercial Proving Grounds, 2 U. ILL. J.L. TECH. & POL’Y 565 (2014)
(discussing cloning in award-winning race and show horses).
46. Lia Eustachewich, These Cloned Dogs Can’t Do Anything Right, N.Y. POST (Jan. 13, 
2017, 2:05 PM), http://nypost.com/2017/01/13/these-cloned-dogs-cant-do-anything-right/.
47. Fiester, supra note 36, at 333.
48. Id.
49. Id.
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The European Food Safety Authority (EFSA) views animal cloning 
as primarily an animal welfare hazard.50 Viability, or “efficiency rates,” 
in converting cloned animal embryos to adult cloned animals is quite low. 
Only 6–15% of mammalian clones survive past infancy, mostly because 
of placenta dysfunctions and the unusually large size of cloned 
offspring.51 Conversely, the mortality rate of those clones who do survive 
is quite high.52 But if companies like Boyalife continue to invest in 
research and development, one could imagine a future where cloned 
animals enjoy relatively healthy lives, especially if the rubric or 
benchmark is common agriculture (“factory-farmed”) animals.53 The 
temporal limitations to the animal welfare argument limit its 
effectiveness. 
These are troubling issues, and prompt the question of why all this 
experimentation is necessary given the availability of naturally produced 
meat. Is the end goal of cloning research to make a uniformly satisfactory 
hamburger?
II. INVENTING NATURE IN THE UNITED STATES
There has been scholarly buzz in response to recent high-profile 
cloning cases. The U.S. Court of Federal Claims in In re Roslin Institute 
(Edinburgh)54 held that Dolly the Sheep was not patentable material,55
but the U.S. Supreme Court in Association for Molecular Pathology v. 
Myriad Genetics Inc.56 determined that synthetically (non-naturally) 
occurring complementary DNA (cDNA) is patentable.57 This technology
is distinct from the more common “embryo splitting” or “nuclear 
transfer” cloning methods, and it works by isolating a homogeneous 
genetic strain in an organism via “an enzyme reverse transcriptase which 
uses the information from RNA to generate complementary DNA.”58
Dolly was deemed unpatentable because she did not represent a 
substantially changed sheep as compared to a baseline conventionally 
bred sheep.59 However, it is still an open question whether a sufficiently 
“newer” kind of sheep might meet this novelty litmus, or whether a 
                                                                                                                     
50. Ignacio Carreño, European Commission Proposes to Revise the EU’s Legislative 
Framework on Novel Foods and Animal Cloning, 5 EUR. J. RISK REG. 362, 364 (2014).
51. Id. at 363–64.
52. Fiester, supra note 36, at 332.
53. Cf. Weimer, supra note 38, at 37.
54. 750 F.3d 1333 (Fed. Cir. 2014).
55. Id. at 1339.
56. 133 S. Ct. 2107 (2013).
57. Id. at 2111.
58. Slack, supra note 31, at 348–50.
59. In re Roslin Inst. (Edinburgh), 750 F.3d at 1339.
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company that clones a food animal via synthetic cDNA could have patent 
rights over the technological process.
In 1873, Louis Pasteur earned a patent for a purified yeast.60 But 
Diamond v. Chakrabarty61 was the first time the Supreme Court ruled a 
human-made, genetically engineered product (here, a bacterium) 
patentable, given that “the patentee has produced a new bacterium with 
markedly different characteristics from any found in nature and one 
having the potential for significant utility.”62 It is unclear how “markedly 
different”63 a Boyalife-designed cow must be to meet the patentability 
standard. Though an unpublished 2012 Federal Circuit opinion, In re 
Ditto,64 indicated that cloned animals that do not differ in claimed aspects 
from naturally occurring animals generally may not be patented.65
Professor Brad Sherman of the University of Queensland suggests that 
judicial characterization and relative framing is key to this analysis, as is 
whether the new product has a new use.66 A cheeky bypass for the patent-
seeking food clone company: to instead market the meat of extinct 
animals like the wooly mammoth or dodo.67 Recreating the extinct animal 
is more likely to meet tests of novelty and nonobviousness.68
The United States is not unique in subjecting cloned animals to the 
same regulations as research animals.69 But because cloned meat animals 
are meant to be consumed—and potentially on a mass scale—they should 
also be subject to public health and environmental regulations.70 This is
especially important because the current USDA definition of a protected 
research “animal” excludes “livestock or poultry used or intended for use 
for improving animal nutrition, breeding, management, or production 
                                                                                                                     
60. Ryan Hagglund, Patentability of Cloned Extinct Animals, 15 GEO. MASON L. REV. 381, 
386 (2008). In April 1988, the PTO issued the first patent for an animal, a Harvard-created 
transgenic mouse. Id. at 403.
61. 447 U.S. 303 (1980).
62. Id. at 310.
63. In re Roslin Inst. (Edinburgh), 750 F.3d at 1339.
64. 499 F. App’x 1 (Fed. Cir. 2012).
65. Id. at 3.
66. Brad Sherman, What Does It Mean to Invent Nature?, 5 U.C. IRVINE L. REV. 1193,
1210–21 (2015).
67. See generally Miriam Ricanne Swedlow, The Woolly-Mammoth in the Room: The 
Patentability of Animals Brought Back from Extinction Through Cloning and Genetic 
Engineering, 11 WASH. J.L. TECH. & ARTS 183 (2015) (discussing the possibility of cloning 
extinct animals).
68. See Hagglund, supra note 60, at 386 (“This article concludes that the statutory 
requirements of patentability of statutory subject matter, novelty, nonobviousness, and utility may 
be met in the cloned extinct animal context and also, patenting these animals is consistent with 
the goals of the patent system.”).
69. See, e.g., Lassen et al., supra note 4, at 1001.
70. Id.
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efficiency.”71 Here there is arguably a regulatory lacuna in the United 
States for cloned animal products (if the United States eventually enters 
this research space for a consumer market).
This seems like an archetypal context for the precautionary principle. 
And while it is true that the FDA has not observed that consumption of 
cloned animal products is deleterious, it is maybe impossible to prove in 
the short term that it is as safe as natural animal proteins.72 The FDA does 
not “determine the safety of proposed GE foods; instead, it evaluates 
whether the GE product is similar to comparable non-GE products.”73 A
related problem is that the FDA will only describe cloned foods as 
“different” if they are in fact “materially” different, a potentially 
capacious and malleable lexical standard.74 In 2008, the FDA authored 
an opinion that food derived from cloned animals does not provide any 
more risks than food from conventionally bred animals.75 Still, the USDA 
and the food industry enacted a voluntary moratorium in 2001.76 So 
despite the regulatory green light from the FDA, it is unlikely that U.S. 
food producers will market cloned foods in the near future.77 It could take 
an additional three to five years for cloned food products to reach the 
consumer once the moratorium ends.78 It is still in effect.79
In contrast, in 2015 the European Parliament “voted to ban the 
cloning of all farm animals as well as the sale of cloned livestock, their 
offspring, and products derived from them.”80 This went beyond a 
proposed 2013 directive that would have implemented a provisional ban 
on just five species of commonly farmed animals.81 This preemptive 
move can be interpreted as both an acknowledgment that cloned foods fit 
awkwardly within the EU’s novel-food paradigm, as well a recognition 
that the U.S. FDA’s noninterference posture could facilitate the furtive 
import of cloned foods into the EU.82 However, this same “hands-off” 
                                                                                                                     
71. 7 U.S.C. 2132(g) (2012).
72. Fiester, supra note 36, at 336.
73. Genna Reed, Rubber-Stamped Regulation: The Inadequate Oversight of Genetically 
Engineered Plants and Animals in the United States, 14 SUSTAINABLE DEV. L. & POL’Y 14, 17 
(2014).
74. Leslie Francis et al., FDA’s Troubling Failures to Use Its Authority to Regulate 
Genetically Modified Foods, 71 FOOD & DRUG L.J. 105, 126 (2016).
75. Weimer, supra note 38, at 33.
76. Id.
77. Id.
78. Id.
79. See, e.g., Reed, supra note 73, at 18.
80. Vogel, supra note 43.
81. Id.
82. Downes, supra note 21, at 271–72.
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FDA attitude makes it unlikely they would try to preempt individual state 
action to limit or label cloned products.83
III. THE FUTURE OF LABELING
In 2016, Vermont became the first U.S. state to require GMO labeling 
on food products.84 Critics immediately questioned whether this move 
comported with a dormant commerce clause85 or the First Amendment.86
The agribusiness industry was also understandably wary of this GMO 
labeling requirement, which was certainly based on Vermonters wanting 
to know which foods possess cloned products so they can avoid eating 
them. Opponents to mandatory GMO labeling spent over $27 million in 
lobbying costs in the first half of 2014 alone.87 Attempting to form a 
compromise between the many consumers who expect transparency in 
where their food comes from and a food industry that wants to avoid a 
patchwork of disparate state labeling requirements, the Obama 
administration and a bipartisan Congress passed a food-labeling bill to 
preempt the Vermont “Right to Know” legislation.88 Instead, the July 
2016 bill S. 764—derided by food activists as the “DARK Act” (Denying 
Americans the Right to Know)—mandates that food labels contain an 
electronic QR code or 1-800 number that discerning buyers can scan or 
call to learn the full GMO history of a product.89 Perhaps for the cyborg 
smartphone-in-hand Generation Z, it is an instinctual move to zap a cold 
                                                                                                                     
83. B. George Walker, Double Trouble: Competing Federal and State Approaches to 
Regulating the New Technology of Cloned Animal Foods, and Suggestions for the Future, 14 J.
TECH. L. & POL’Y 29, 46 (2009).
84. Terri Hellenbeck, Vermont Gov Signs Law to Require Labels on GMO Foods, USA
TODAY (May 8, 2014, 4:14 PM), https://www.usatoday.com/story/news/politics/2014/
05/08/genetically-modified-foods/8860423/.
85. See, e.g., Sabrina S. Adler et al., You Want a Warning with That? Sugar-Sweetened 
Drinks, Safety Warnings, and the Constitution, 71 FOOD & DRUG L.J. 482, 514 (2016); see also
Ross H. Pifer, Mandatory Labeling Laws: What Do Recent State Enactments Portend for the 
Future of GMOs?, 118 PENN ST. L. REV. 789, 806–07 (2014) (suggesting Vermont’s GMO 
labeling law could be challenged as violating the U.S. Constitution’s dormant Commerce Clause). 
86. Omri Ben-Shahar, Vermont’s GMO Labeling Law Violates the First Amendment,
FORBES (June 1, 2016), https://www.forbes.com/sites/omribenshahar/2016/06/01/gmo-science-
and-the-constitution-vermonts-labeling-law-violates-the-first-amendment/#1d63024a51f1.
87. George A. Kimbrell & Aurora L. Paulsen, The Constitutionality of State-Mandated 
Labeling for Genetically Engineered Foods: A Definitive Defense, 39 VT. L. REV. 341, 345 (2014).
88. Mark Hay, Why Trump’s Quiet Crusade Against Regulations Matters, VICE (June 9,
2017), https://www.vice.com/en_us/article/zmezdy/why-trumps-quiet-crusade-against-
regulations-matters (“[F]ood manufacturers want a federal regulation on how and when to label 
products containing genetically modified elements so they won't have to flounder in a patchwork 
of state regulations.”). 
89. Michael Addady, President Obama Signed This GMO Labeling Bill, FORTUNE (July 31, 
2016), http://fortune.com/2016/07/31/gmo-labeling-bill/.
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cut or munchie with an iPhone. To older consumers, this feels like a 
clunky shopping experience and would likely chill them from taking the 
extra steps to learn the genetic provenance of a food item. Further, a QR 
code is not useful to those who do not own a smartphone, such as some 
low-income and rural persons.90
The USDA is delegated with the authority to (1) decide how visible 
or accessible these labels will be and (2) determine what “counts” as 
genetically modified or what sorts of modifications are important enough 
to be electronically accessible.91 Interestingly, the USDA’s marketing 
section is managing this process, given that the department already 
assumes the healthfulness of genetically modified ingredients.92
However, with the new Trump administration, there is uncertainty 
regarding when and if the USDA will publish these new labeling 
regulations. In January 2017, the administration announced a “two-for-
one” rule, which requires deleting two old regulations prior to making a 
new one.93 President Trump has previously suggested he favors GMO 
foods in this debate, in keeping with his general laissez-faire attitude 
toward regulation.94 Nevertheless, Trump has also proven to be adaptive 
in policy positions outside of core interests like international trade.
At a very recent food labeling conference, USDA Senior Policy 
Analyst Andrea Huberty confirmed that the department is still on track to 
publish the new labeling requirements.95 In addition, it seems 
jurisprudentially important that this bill was passed with congressional 
support, rather than as a mere executive order. This procedural distinction 
arguably makes it harder for the bill to simply go void with the 2018 
eclipse date.96 For now, the Vermont Right-to-Know legislation is 
preempted despite the lack of movement at the federal level. If this 2018 
eclipse date is passed, will Vermont—and like-minded states—be able to 
enact more stringent state labeling laws once again?
                                                                                                                     
90. PEW RESEARCH CTR., MOBILE FACT SHEET (Jan. 12, 2017), 
http://www.pewinternet.org/fact-sheet/mobile/.
91. Glenn S. Kerner, Food for Thought: The Federal GMO Labeling Law, FOOD SAFETY
(Feb./Mar. 2017), http://www.foodsafetymagazine.com/magazine-archive1/februarymarch-
2017/food-for-thought-the-federal-gmo-labeling-law/.
92. Megan Poinski, USDA on GMO Labeling Law: ‘Still on Track, but a Little Behind,’
FOOD DIVE (June 7, 2017), http://www.fooddive.com/news/usda-on-gmo-labeling-law-still-on-
track-but-a-little-behind/444383/.
93. Ian Kullgren, GMO Labeling Fans, Trump Just Slowed Your Roll, POLITICO (Jan. 31, 
2017, 10:01 AM), http://www.politico.com/tipsheets/morning-agriculture/2017/01/gmo-
labeling-fans-trump-just-slowed-your-roll-218500.
94. Kerner, supra note 91 (“Indeed, Trump himself answered ‘yes’ on the campaign trail in 
2015 when the Iowa Farm Bureau asked him if he supported the use of biotechnology in food and 
opposed efforts to require mandatory labeling just because a food contains GMOs.”).
95. Poinski, supra note 92.
96. Kullgren, supra note 93.
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IV. TRACKING THE PAST
This Article argues that eating factory-to-table cloned meat is 
decidedly weird. But perhaps the more difficult question is how to track 
the descendant generations of cloned animals—what about animals that 
were conventionally bred to a cloned parent (or grandparent, etc.)? How
to identify for the discerning consumer whether a born animal possesses 
the genetic inheritance of a cloned ancestor? Historically, the United 
States has had one of the most relaxed stances on GMO products,97 and 
it is unclear when or if these Obama-era regulations will go into effect.
However, organic retailers such as Whole Foods will still want to 
distinguish their product as natural in the primordial sense.98 This kind of 
“reverse labeling”99 or “private labeling”100 to signify a food’s natural 
pedigree can put consumers on notice of the possible cloned heritage of 
unlabeled foods. But one damaging rejoinder: It is widely thought that 
milk and meat of cloned provenance have already furtively entered the 
food supply.101 In countries such as the United States and Argentina,
cloning is already used for commercial purposes, even in the absence of 
mandatory traceability.102 If clones have already entered the food chain,
only “a proper segregation can distinguish the clones’ offspring products 
from conventional products.”103 There is USDA confirmation that meat 
animals who themselves consume feed made of GMO products, as well 
as the products that are disproportionately made from these foods such as 
chicken soup or SPAM, will not receive the GMO QR code or 1-800 
number in a possible new labeling regime.104 If these foods are cleared as 
non-GMO for USDA purposes, it seems unlikely the Obama bill would 
                                                                                                                     
97. Harrison Joss, The Rise of Frankenbeer: A Holistic Analysis on International Labeling 
and Beverage Laws Through the Lens of the Ongoing Controversy of Genetically Modified 
Organisms, 21 ILSA J. INT’L & COMP. L. 131, 134 (2014). Joss later notes that “labels must be 
placed on any foodstuffs where the GM content exceeds even 0.9% of the original ingredient.” 
Id. at 148.
98. See, e.g., Farm Animal and Meat Standards, WHOLE FOODS MARKET,
http://www.wholefoodsmarket.com/farm-animal-meat-quality-standards (last visited Oct. 8, 
2017).
99. Francis et al., supra note 74, at 127.
100. Marine Friant-Perrot & Lise Rihouey, Failure of Conciliation Talks on the Use of 
Animal Cloning for Food: “The Consumer’s Right to Make Informed Food Choices,” 2 EUR. J.
RISK REG. 414, 415 (2011).
101. E.g., AFP-JIJI, Dolly’s Legacy: Are You Eating Cloned Meat?, JAPAN TIMES (July 23,
2016), https://web.archive.org/web/20160817191721/http://www.japantimes.co.jp/news/2016/
07/23/world/science-health-world/dollys-legacy-eating-cloned-meat#.WbR9pNGQyCo
(answering “probably”).
102. Friant-Perrot & Rihouey, supra note 100, at 415.
103. Id. at 414.
104. Poinski, supra note 92.
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capture the difficult category of milk from a cow that is thought to 
descend from a cloned ancestor. 
Further, it is unclear how an EU-based moratorium can prevent the 
diffusion of cloned progeny into the food supply.105 However, similar 
sorts of traceability requirements have been implemented in the past, such 
as those imposed during the BSE (“mad cow”) crisis in the United 
Kingdom.106 Either way, companies looking to trade in cloned animal 
products will face the challenge of export to Europe, Japan, and other 
nations whose citizens are anxious of genetically engineered foods.107
V. TRADE CHALLENGES
The international trade of cloned animal products does not fit squarely 
within World Trade Organization (WTO) jurisprudence. The Appellate 
Panel is skeptical of process-based distinctions,108 and the Sanitary and 
Phytosanitary Measures (SPS) Agreement is understood to constrain the 
autonomy of national governments. Recently, the United States, Canada,
and Argentina cited to the SPS Agreement to successfully challenge the 
EU moratorium on GMOs.109 Still, we can sketch out the various 
arguments the EU might make in regard to cloned animal products. A 
“right-to-know” challenge to learn the ingredients or provenance of a 
food would be very difficult to implement given the scale of things like 
the milk industry and the amount of science involved with determining 
whether a dairy cow has a cloned ancestor several generations removed. 
Skeptics like the Hungarian Prime Minister Sándor Fazekas have quipped 
whether a salami must now be packaged with a copy of its family tree.110
Country of origin labeling (COOL) has also been challenged by beef-
exporting nations including Canada and Mexico, who argue consumers 
inherently prefer local product.111
Another argument is that cloned food is “unlike” an uncloned food 
per GATT Article III.112 Under this theory, consumer preferences are 
                                                                                                                     
105. See id.
106. Ludivine Petetin, The Revival of Modern Agricultural Biotechnology by the UK 
Government: What Role for Animal Cloning?, 7 EUR. FOOD & FEED L. REV. 296, 303 (2012).
107. Reed, supra note 73, at 19.
108. Scarlettah Schaefer, Let’s Stop Worrying and Learn to Love Transparency: Food and 
Technology in the Information Age, 10 J. FOOD L. & POL’Y 233, 250 (2014) (“Under WTO rules, 
process-based measures elicit stricter scrutiny and require more justification than product-based 
measures.”).
109. Joss, supra note 97, at 144.
110. Downes, supra note 21, at 281.
111. Cassidy L. Woodard, From Cattle Drives to Labeling Legislation: The Implications of 
Mandatory Country of Origin Labeling on the Beef Industry, 47 TEX. TECH L. REV. 399, 412 
(2015).
112. Downes, supra note 21, at 275.
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considered to be evidence of the likeness of products. Thus, if consumers 
strategically avoid products of cloned provenance, this might go to the 
Appellate Panel’s calculus of whether they are distinguishable on the 
international market. The recent dismissal of US–Clove Cigarettes could 
also be helpful precedent for the EU.113
A likely reference is to the GATT XX(a) chapeau on public morals. 
In brief, the EU could argue that animal cloning specifically, or 
mammalian cloning more broadly, is in conflict with EU values. The 
Appellate Panel is less deferential to idiosyncratic national preferences, 
which could be provincial, insular, or pretextual. Instead, in US-
Gambling, the Panel “heavily relied on international expressions” of 
morality.114 Big agriculture has generally not advertised cloning 
processes, and because of this there are not very well developed 
perspectives on cloning. And it is difficult to posit any consensus on the 
morality of animal cloning. Instead, this Article argues that a public 
morality argument should be recharacterized as cloning living mammals.
This broader heuristic would capture humans as well as other agricultural 
animals that we eat, or companion or security animals that we use. 
However, it delimits in vitro meat, human–pig embryos, and other 
disembodied organs of this ilk. The benefits of an argument based on 
species integrity is that it has universal salience and does not depend on 
personal religion, ethics, or affinities. However, this might not extend to 
outlier groups like post-humanists or rogue scientists like Richard 
Seed.115
Our sense of core humanity depends on shared assumptions of what 
characterizes the human body and the possibilities of human experience. 
However, a singular element that makes us uniquely human is perhaps 
impossible to discern. The religious use the vocabulary of the soul; 
secularists retreat to inspiring but vague words such as dignity or Francis 
Fukuyama’s multivariate “Factor X.” Trends in body modification, more 
enlightened perspectives of gender identity, transcendental meditation,
and perhaps even psychotropic drugs have helped to refine and contour 
notions of what it means to be human. But these are still individual 
expressions. So, a potential Boyalife-Sooam genetic uber-human is 
distinguished. The inherent competition in a capitalist, globalized society 
creates the conditions of a race-to-the-bottom marketplace for human 
enhancement. A potential Boyalife–Sooam genetic clone brings in 
separate, but still profound, concerns. Here, the hypothetical is not how 
we will react to a cohort of genetically enhanced humans, but how we 
will respond to the creation of other humans produced in our mirror 
image. 
                                                                                                                     
113. Id. at 275–76.
114. Id. at 277.
115. Annas et al., supra note 3, at 161–62.
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The specific facts of a factory-to-table meat clone beg for a necessity 
challenge per GATT Article XX or TBT Article 2.2. Here, the Appellate 
Panel would likely employ a “relational analysis” that weighs and 
balances various factors.116 But how would the Panel define these various 
factors? The goal or “pro” of cloned-meat, in vitro-meat, and faux-meat 
producers is uniformly shared: to make a product that most closely 
resembles the taste of natural high-quality meat. This makes cloned meat 
manifestly unnecessary, as the natural equivalent already exists. The 
balance, or “con,” has multiple layers. In the first circle are immediate 
problems of “low efficiency” in cloning, animal suffering, decreased 
genetic diversity, and a corollary increased vulnerability to animal 
epidemics.117 In expanding concentric circles are human-experience 
concerns, including a revised view of our internal order of food, ecology,
and self. The very apples-and-oranges nature of this orthogonal and 
relational analysis seems to negate the relevance of a trade necessity 
analysis. The slippery slope from fully-formed animal clones for direct 
meat consumption to human experimentation makes this both a difficult 
moral problem to articulate and one so immediately profound that the 
Panel should err on the side of caution.
VI. PARADOXES: EQUIVALENT, NEW, OR NEITHER?
Fully-formed animal clones subvert the kinds of analyses done in 
patent and WTO law and the construct of “novel foods” used in EU law. 
To be a novel food in the EU, a food must (1) have not been used to a 
significant degree by humans prior to May 1997 and (2) be a food that 
falls within one of four categories: “food with modified primary 
molecular structure; food isolated from microorganisms; foods isolated 
from plants, food ingredients and animals; foods produced by novel 
processes.”118 Cloned meat has never fit well within traditional 
definitions of novel products.119 The paradox is fairly intuitive: It is “the 
inherent truth that something cannot be new if it existed in nature before 
being discovered.”120 But if you are creating the same thing with a wholly 
novel process, does this count as new? And a corollary question: Are we 
sure the cloned version is the same thing as an organic, “naturally”
occurring plant, animal, or animal part? 
                                                                                                                     
116. Downes, supra note 21, at 278.
117. Petetin, supra note 106, at 297.
118. Downes, supra note 21, at 253.
119. Id. at 271.
120. Hagglund, supra note 60, at 389; see also Sherman, supra note 66, at 1210 (“[A] claim 
will not be patentable if the only innovation in the patent was the use of natural phenomenon.”);
Slack, supra note 31, at 351 (discussing whether a cloned animal is something that existed in 
nature before being discovered).
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The EU employs a substantial-equivalence test in regard to novel 
foods and “relies on the comparative analysis of conventional and biotech 
foods.”121 It is criticized as subjective and as lacking standardized tests
or a definition of “substantial.”122 However, it is also paradigmatically 
cautious. It might not always produce internally coherent reasons to 
exclude product entry and be overbroad in excluding foods that are 
genuinely healthful, delicious, noncancerous, and more. But at least for 
foods that might mask unknown problems, such as rBST milk,123 it makes 
sense to err on the side of caution. Alternatively, the science-driven 
process of the FDA takes a wait-and-see approach by permitting the entry 
of a novel product into the market until there is evidence of it having 
deleterious consequences on public health.124 As cloned meat is 
indistinguishable from non-cloned meat by current food-analysis testing, 
such that a laboratory test cannot detect a difference, there is no material 
difference per the FDA calculus.125 This contrasts with the precautionary 
principle associated with EU law.
VII. RECONCILING PRECAUTION, RISK, AND THE HUMAN EXPERIENCE
The immediate American connotation of the precautionary principle 
is the Burkean axiom to not risk the unknown without a good reason.126
However, this is an incomplete understanding of the European 
application, which possesses ethical content and is recognized as a 
“culturally framed concept.”127 Professor Clavier emphasizes the 
emotional importance of food to many European countries. For nations 
such as France and Italy, “[a]ny alteration of the culinary tradition is 
easily perceived not only as an attack on the cultural heritage, but also as 
an imperialist takeover of the cultural identity, especially if it comes from 
the United States.”128 Readers might be surprised to learn of the so-called 
“Pork War”129 of 1881 between the United States and France. This war 
against American pork is evidence of the embeddedness of food 
production within these European cultures, and helps to explain the 
emotional significance of the precautionary principle and how it 
                                                                                                                     
121. Petetin, supra note 106, at 304.
122. Id. at 305.
123. Id. at 304.
124. E.g., Lucas Bergkamp & Lawrence Kogan, Trade, the Precautionary Principle, and 
Post-Modern Regulatory Process: Regulatory Convergence in the Transatlantic Trade and 
Investment Partnership, 4 EUR. J. RISK REG. 493, 497–98 (2013).
125. Norton, supra note 14, at 170.
126. Clavier, supra note 29, at 8.
127. Id. at 9–10.
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operates.130 I have written elsewhere on the equation of self, identity, and 
food politics with France and foie gras, and have questioned the claim of 
the Israel Supreme Court that gourmet foods are mere luxury.131 How we 
define food—and here, cloned meat—is essential to the process and 
production methods (PPM) legal analysis. If food is viewed exclusively 
as sustenance, it becomes easier to equate meat with its chemistry, caloric 
makeup, and nutrition profile, among other things. However, if it is
conceptualized as interwoven with our social fabric, the intricacy or 
purity of process does not register as delicate. Rather, it is perceived as 
imperative to achieving a vision of cultural identity for those who partake 
in these foods. 
The embeddedness of the European precautionary principle is 
directly relevant to the trade of cloned meat. I can understand why milk 
derived from the progeny of an ancestor clone can be reduced to the 
superficial physiological question of whether it is materially different 
from nonorganic milk or milk containing the enzyme rBST,132 or even 
Parmalat or the notorious Carolene filled-milk product made historical by 
Footnote Four of that New Deal litigation.133 Milk feels separate from the 
lactating cow, and there is enough of a spectrum of “milk” on the market 
from various animals, plant proteins, and processing that the cloned 
ancestor can be rationalized, compartmentalized, or otherwise forgotten. 
Meat, on the other hand, is different. Eating the cloned factory-to-table 
“flesh” of an engineered animal distorts our sense of self and ecology. 
The ineluctable weirdness of eating Dolly the Sheep is captured by this 
European accent to the precautionary principle. We expect eating cloned 
meat will affect our (social) psychology, but it is difficult to predict 
exactly how. Professor David Owen offers the construct of “foreseeable 
unforseeability” to describe the paradox of a laissez-faire approach to 
transformative technological processes.134 This Article does not articulate 
why consuming factory-produced animals for their meat is meaningfully 
different from other sorts of tech food. However, the European 
precautionary principle does not require precise language. Its emotional 
thrust can depend on the nebulous, inchoate feelings that already typify 
our sense of place and ritual at the dinner table.
                                                                                                                     
130. See id.
131. Andrew Jensen Kerr & Yu Dan, Tradition as Precedent: Articulating Animal Law 
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133. United States v. Carolene Prods. Co., 304 U.S. 144, 152 n.4 (1938).
134. See generally David G. Owen, Bending Nature, Bending Law, 62 FLA. L. REV. 569
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race).
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Therefore, this Article echoes Professor Clavier’s notion that a 
revised precautionary principle can allow the WTO to move away from 
a strictly functionalist perspective. This move respects the nonrational 
elements of food and cloning and can reconcile “liberalization of 
agriculture and food products and consumer anxiety linked to new 
technology.”135 Importantly, the precautionary principle is already a 
valorized norm in other aspects of U.S. food law. The Food Quality 
Protection Act of 1996 “mandates a precautionary safety factor in 
addition to an ample margin of safety.”136 The precautionary principle 
allows courts and tribunals to work within the law, rather than have to 
create “bad law” in response to “bad facts” and concomitantly create 
outlier, unworkable legal categories. 
It is true that a corollary to precaution is possibly limiting innovation 
based on excessive solicitude or outlier Lysenko-ish science. Professors 
Lucas Bergkamp and Lawrence Kogan describe a post-modern view of 
the precautionary principle in which a “policy-based science” of worst-
case scenarios distorts the traditionally probabilistic nature of science-
based policy.137 These are fair objections. But this Article emphasizes the 
qualitative aspects of the precautionary principle, and does not argue for 
a lower standard of scientific authority. Rather, this Article suggests an 
expanded notion of risk beyond “the cold arithmetic of cost-benefit 
analysis” to a framework where “science, risk and society” are integrated
instead.138 It is not a matter of lessening the standard of science but 
increasing the weight attached to social disruption and the dialectical 
relationship between food and the social order.
CONCLUSION
The WTO has been a fountainhead of jurisprudence on animal ethics 
and public morality in Tuna-Dolphin,139 Shrimp-Turtle,140 and the 
Canadian seal-hunt litigation.141 Animal cloning might be the next 
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iteration in this line of cases.142 For example, cloned products such as 
semen or embryos for artificial insemination are already traded 
globally.143 It will be interesting to see if and how the Appellate Panel 
draws lines to promote agricultural innovation while maintaining core 
aspects of the human experience.
This Article suggests that the international community should
continue to take a hard look at these cloning factories. Animals are too 
easily cloistered from public view, especially when they can be 
categorized as legal things rather than persons. So far, it seems that 
Boyalife wants to display their innovation, as they are planning to curate 
a museum in their corporate campus. Still, the more interesting study is 
the social experiment outside of Boyalife. If we do begin eating cloned 
animals for meat, how will this affect our own internalized notions of 
humanity, economy, and food production? Perhaps we will have to 
recalibrate what values are truly necessary when deciding the kinds of 
novel products we might soon consume.
                                                                                                                     
Marketing of Seal Products, WTO Doc. WT/DS400/AB/R (May 22, 2014) (discussing Canadian 
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